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PreviewsVitamin C (ascorbate/ascorbic acid) is a 
water-soluble molecule that is essential 
for life. Ascorbate is a cofactor for cop-
per-dependent monooxygenases (such 
as dopamine-β-hydroxylase) and iron-de-
pendent dioxygenases (such as collagen 
prolyl and lysyl hydroxylases). It is also an 
antioxidant that prevents cellular damage 
from oxygen radicals. Most vertebrates 
satisfy their need for ascorbate by synthe-
sizing it de novo from glucose, but some 
mammals including humans have lost this 
ability and must obtain vitamin C from 
their diets. Vitamin C deficiency leads to 
a disease called scurvy, first described 
by Hippocrates, which is characterized 
by liver spots on the skin, gingival hyper-
plasia, and bleeding from mucous mem-
branes. For the rare mammalian species 
that do not synthesize vitamin C, ascor-
bate and its oxidized form dehydroascor-
bate (DHA) are taken up from the diet and 
carried in the plasma to cells throughout 
the body (Rose, 1988). Cells then read-
ily reduce DHA to ascorbate. Many cells 
have high-affinity transporters for vitamin 
C, but mature red blood cells (RBCs) do 
not have these transporters and can-
not take up vitamin C from plasma (May, 
1998). In this issue, Montel-Hagen et al. 
(2008) demonstrate that the glucose 
transporter Glut1 of mature human RBCs 
enables efficient uptake of DHA by these 
cells. They then determined that there is a 
switch in Glut1 substrate specificity from 
glucose to DHA that is regulated by sto-
matin, a membrane protein that binds to 
Glut1. The switch in substrate affinity of 
Glut1 is a unique feature of those mam-
mals that are incapable of de novo syn-
thesis of vitamin C.
It is well established that DHA is a 
substrate for the glucose transporter 
Glut1 and competes with glucose, albeit 
weakly, for transport by ectopically 
expressed Glut1 (Rose, 1988; Bianchi 
and Rose, 1986; Vera et al., 1993) 
(Figure 1). Montel-Hagen et al. (2008) 
now report that mature human RBCs, 
unlike erythrocytes from most species, 
express very high levels of Glut1. They 
observe that whereas Glut1 expression 
increases during erythrocyte differen-
tiation, paradoxically, the rate of glu-
cose transport decreases. In contrast, 
the rate of DHA uptake increases dra-
matically with RBC differentiation, and 
glucose is no longer a competitive sub-
strate for transport. In considering how 
the substrate affinity of Glut1 could be 
affected, the authors capitalized on the 
knowledge that the membrane protein 
stomatin is a Glut1-binding protein and 
when ectopically expressed reduces 
the affinity of Glut1 for glucose (Zhang 
et al., 2001). Montel-Hagen and col-
leagues extend this observation by 
showing that expression of stomatin 
increases the affinity of Glut1 for DHA 
and reduced the ability of glucose to 
compete with DHA. The investigators 
also showed that expression of stoma-
tin, like Glut1, increases during differ-
entiation of RBCs. Humans with a rare 
genetic disease (overhydrated heredi-
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Most vertebrates synthesize vitamin C (ascorbate) de novo from glucose, but humans and certain 
other mammals cannot. In this issue, Montel-Hagen et al. (2008) demonstrate that erythrocytes 
from these ascorbate auxotrophs switch the preference of their glucose transporter Glut1 from 
glucose to dehydroascorbate (DHA), the oxidized form of vitamin C. This substrate preference 
switch is mediated by the membrane protein stomatin and is an evolutionary adaptation to vitamin 
C deficiency.
Figure 1. Uptake of Vitamin C Precursors by Erythrocytes
Most mammals are capable of de novo synthesis of vitamin C (ascorbic acid) from glucose, which is tak-
en up by transporters of the Glut family, Glut1 or Glut4, expressed by red blood cells (RBCs). In humans 
and certain other mammals incapable of de novo vitamin C synthesis, the affinity of glucose and another 
vitamin C precursor called dehydroascorbate (DHA) for the transporter Glut1 is altered by the membrane 
protein stomatin. Immature human RBCs express Glut1 and primarily take up glucose in preference to 
DHA. During RBC differentiation, expression of stomatin increases. Stomatin binds to Glut1 and changes 
its substrate preference from glucose to DHA. Within RBCs, DHA is then reduced to ascorbic acid and is 
released back into plasma thus increasing the plasma concentration of vitamin C.Cell 132, March 21, 2008 ©2008 Elsevier Inc. 921
tary stomatocytosis) produce too little 
stomatin. Montel-Hagen et al. found 
that RBCs from these patients have 
higher rates of glucose transport and 
lower rates of DHA transport than wild-
type cells, confirming the role of sto-
matin in modulating DHA uptake.
Humans are part of a select group 
of vertebrates that have lost the abil-
ity to synthesize ascorbic acid. Other 
ascorbic acid “auxotrophs” include the 
Haplorrhini suborder of primates (New 
World monkeys, Old World monkeys 
and apes), guinea pigs, and fruit bats. 
Montel-Hagen and coworkers dem-
onstrate that mature RBCs of these 
ascorbate auxotrophs express high 
levels of Glut1 and have correspond-
ingly high rates of DHA uptake. Mature 
RBCs from animals that are able to 
synthesize ascorbic acid (including 
lemurs) take up smaller amounts of 
DHA. The authors conclude that sto-
matin, by binding to Glut1, enables the 
mature RBCs of ascorbic acid aux-
otrophs to take up DHA, which then 
can be converted into ascorbic acid. 
The increased expression of Glut1 by 
mature RBCs appears to be an adap-
tive response to the loss of de novo 
ascorbic acid synthesis.
In humans, other members of the 
Haplorrhini primate subgroup, and 
guinea pigs, the inability to synthesize 
ascorbic acid is due to mutations in the 
enzyme L-gulono-γ-lactone oxidase 
(GLO) that result in its inactivation. 
The inactivating event in guinea pigs is 
relatively recent (20 million years) and 
occurred after this species diverged 922 Cell 132, March 21, 2008 ©2008 Elsevifrom other vertebrates (Nishikimi et al., 
1992). It is not clear when fruit bats lost 
the ability to synthesize vitamin C, but 
that too is due to inactivation of GLO. 
Each of these species has responded 
by increasing the uptake of DHA by 
RBCs through increased expression 
of Glut1. What has not been shown, 
but is inferred, is that enhanced DHA 
uptake is due to an interaction between 
Glut1 and stomatin. Did this evolution-
ary solution to vitamin C deficiency 
occur independently three times (pri-
mates, guinea pigs, and fruit bats)? Or 
is stomatin-altered Glut1 activity also 
a conserved feature of the tissues (but 
not RBCs) from vertebrates capable of 
synthesizing ascorbic acid?
DHA is efficiently recycled to vitamin C 
within RBCs (and other cells) even though 
RBCs do not have the dioxygenase 
enzymes for which vitamin C serves as 
a cofactor (Arrigoni and De Tullio, 2002). 
Vitamin C may have an antioxidant effect 
on erythrocyte membranes, as one of 
the symptoms of scurvy is decreased 
RBC life span. In contrast to species 
capable of de novo vitamin C synthe-
sis, mature RBCs of species that cannot 
synthesize vitamin C are likely to be an 
important source of vitamin C in plasma 
(May, 1998). Vitamin C does not seem 
to accumulate in RBCs, as the level of 
cytosolic ascorbic acid is similar to that 
in plasma. These data suggest that vita-
min C is efficiently excreted by RBCs into 
plasma where it acts as an antioxidant 
preventing peroxidation of plasma lipo-
proteins (Frei et al., 1990) and also as a 
source of vitamin C for other cell types.er Inc.Vitamin C has had a colorful history 
as a therapeutic agent. The authors 
point out the interesting fact that many 
of the recommended vitamin C daily 
requirements were determined using 
mice and rats with an inactivated 
GLO enzyme. The amount of vitamin 
C required to alleviate symptoms of 
scurvy is much higher than the levels 
found in humans (Pauling, 1970). This 
difference might be the result of the 
ability of human RBC Glut1 to accumu-
late and convert DHA to ascorbic acid. 
Recommended doses of vitamin C for 
humans may be excessive, as they do 
not take into account this evolutionary 
adaptation to ascorbic acid deficiency.
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